I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...
About
The Medical Devices Regulatory Track Learning Path is designed to equip professionals with the comprehensive regulatory, quality, clinical, and post-market knowledge required to bring medical devices and in vitro diagnostics to market and maintain their compliance throughout the product lifecycle. Covering EU MDR 2017/745, EU IVDR 2017/746, ISO 14971:2019 risk management, ISO 13485:2016 quality systems, GCP for medical devices under ISO 14155:2026, FDA 21 CFR Part 820, device safety and vigilance, CAPA management, and regulatory inspection readiness, this programme provides an end-to-end regulatory competency framework for the medical device sector.
Participants will develop an understanding of the EU and US regulatory frameworks for medical devices and IVDs, the quality system requirements that underpin compliant device development and manufacture, risk management obligations under ISO 14971, clinical investigation standards, and the post-market surveillance and vigilance activities required to maintain device approval and patient safety.
How this differs from the Quality & Compliance Professional Learning Path
The Medical Devices Regulatory Track is sector-specific — it focuses on the regulatory frameworks, classification systems, clinical investigation standards, and post-market vigilance requirements that are unique to medical devices and IVDs. It is designed for regulatory affairs specialists, quality professionals, and clinical research teams working specifically within the medical device industry.
In comparison, the Quality & Compliance Professional Learning Path provides a broader pharmaceutical and life sciences quality management education — covering GMP, ISO 9001, deviation management, and validation across pharmaceutical manufacturing and clinical settings. Professionals working at the intersection of device and pharmaceutical regulation may benefit from completing both learning paths.
Courses Included

Comprehensive overview of EU MDR 2017/745 — device classification, conformity assessment routes, UDI, notified body requirements, and transitional provisions

EU IVDR 2017/746 framework — IVD classification, performance evaluation, common specifications, and regulatory transition from IVDD

ISO 14971:2019 risk management process — hazard identification, risk estimation, risk evaluation, risk control, and residual risk acceptability for medical devices

ISO 13485:2016 QMS requirements for device manufacturers — design controls, production, complaints handling, and regulatory compliance throughout the device lifecycle

GCP requirements for clinical investigations of medical devices under ISO 14155:2026 — clinical evaluation, investigation plan design, ethics committee requirements, and EU MDR alignment

FDA Quality System Regulation (QSR) under 21 CFR Part 820 — design controls, CAPA, complaint files, and manufacturing quality requirements for US medical device manufacturers
Our Certified Customers
Learner Rating & Reviews
Frequently Asked Questions
- Regulatory affairs professionals in medical device and IVD companies
- Quality assurance managers and internal auditors in device manufacturing
- Clinical affairs and clinical evaluation specialists
- Post-market surveillance and vigilance officers
- Design and development engineers with regulatory compliance responsibilities
- Notified body audit preparation leads and quality system managers
- Healthcare professionals and researchers involved in device clinical investigations
- Professionals transitioning from pharmaceutical regulatory roles into medical device regulation
- Life sciences graduates pursuing careers in medical device regulatory affairs or quality
Upon completion of this learning path, participants will be able to navigate the EU MDR and IVDR regulatory frameworks, apply ISO 14971:2019 risk management processes, implement and audit ISO 13485:2016 quality management systems, conduct GCP-compliant clinical investigations under ISO 14155:2026, ensure FDA QSR compliance under 21 CFR Part 820, manage post-market surveillance and vigilance obligations, and maintain inspection-ready documentation for notified body and competent authority review.








